Verapamil has been associated with anticarcinogenic activity because it can inhibit P-glycoprotein, a protein associated with cancers with multidrug resistance phenotype when combined with chemotherapeutic agents due to its ability to promote intracellular drug accumulation (152). Here, ABCB1 is linked to cancer.